Case Statement

Novo Biosciences is a regenerative medicine company developing small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals.

To learn more about our latest lead molecule, ZF-143, download our case statement >

Novo Biosciences is currently seeking scientific partners and investors as we continue to build our team and secure funding. To discuss partnership opportunities, please contact a member of our executive team at 207.288.5670 or by email:

• Kevin Strange, Ph.D., Co-founder and Chairman: kevin.strange@novobiosciences.com
• Voot Yin, Ph.D., Co-founder and Chief Scientific Officer: voot.yin@novobiosciences.com